Horizons Marijuana Life Sciences Index ETF
Most Recent
Acreage Holdings: Analysts Weren’t Pleased after Disappointing Q1
Investors and analysts weren’t pleased with Acreage Holdings’ (OTCMKTS:ACRGF) results for the first quarter of 2020. The company posted another EBITDA loss.
Why Is Raymond James Bullish on Cronos Group?
Earlier this week, Rahul Sarugaser of Raymond James upgraded Cronos Group (NASDAQ:CRON) from “market perform” to “outperform.”
Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish
Aurora Cannabis (NYSE:ACB) announced some business transformation plans on June 23. The plans included cost savings and margin improvement.
Aurora Cannabis Announces Job Cuts and Facility Closures
On Tuesday, Aurora Cannabis (NYSE:ACB) provided an update on its business transformation plan, which it announced earlier this year.
Why Canadian Cannabis Sales Dipped Slightly in April
In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.
Marijuana Legalization Catches Federal Reserve Bank’s Attention
The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.
Why HEXO Stock Tanked More than 11% on Wednesday
On Wednesday, HEXO announced a new at-the-market equity program, which would allow it to issue common shares worth up to 34.5 million Canadian dollars.
Will the Abacus Health Acquisition Benefit Charlotte’s Web?
On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.
OrganiGram Stock Rose Due to New International Agreement
On Wednesday, OrganiGram Holdings (NASDAQ:OGI) announced that its subsidiary OrganiGram signed a supply agreement with Canndoc.
Green Thumb Industries Opens Its 46th Retail Store
On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.
Is Canopy Growth a ‘Buy’ after Its Recent Pullback?
Since Canopy Growth (NYSE:CGC)(TSE:WEED) reported its results for the fourth quarter of fiscal 2020, it has lost 22.4% of its stock value as of Tuesday.
Why Is HEXO Rising before Its Q3 Earnings?
HEXO (TSE:HEXO) will likely report its third-quarter earnings before the market opens on June 11. So far, HEXO has lost 58.9% of its stock value this year.
Aurora Cannabis Continues to Shine: Should You Book Profits?
As of June 5, Aurora Cannabis was trading at 18.79 Canadian dollars—a rise of 104.2% since it reported its third-quarter earnings.
How’s COVID-19 Impacting Cigarette and Cannabis Sales?
Layoffs amid COVID-19 led to a decline in disposable income, which had a negative impact on the cigarette and cannabis industries.
Why Does Paradigm Capital Favor OrganiGram Holdings?
Paradigm Capital analyst Corey Hammill is bullish on OrganiGram. He rated the stock as a “buy” with a target price of 4.00 Canadian dollars.
HEXO Launches New Tsunami Format, Targets Medical Customers
On Wednesday, HEXO launched its high-THC strain Tsunami in a new 30-gram pack exclusively for medical usage. The launch impressed investors.
Analysts Are Bearish after Canopy Growth’s Weak Q4 Earnings
Canopy Growth (NYSE:CGC)(TSE:WEED) reported its fourth-quarter earnings before the market opened on May 29. The company’s earnings were weak.
HEXO Received License Amendment, Stock Rose Monday
On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario.
Why Are Canadian Cannabis Companies Leaving Jamaica?
Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.
Why Is Raymond James Bullish on OrganiGram?
Rahul Sarugaser of Raymond James is upbeat on OrganiGram Holdings (NASDAQ:OGI). The company amended its credit facility with the Bank of Montreal.
Did MedMen’s Q3 Earnings Start a Path to Recovery?
MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.
Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.
Why Analysts Still Aren’t Convinced about Aurora Cannabis
Since Aurora Cannabis reported its third-quarter earnings, Piper Sandler upgraded the stock from “underweight” to “neutral.” Analysts favor a “hold” rating.
Why Analysts Had Mixed Reactions to Aphria’s Q3 Earnings
On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.
Comparing Canopy Growth and Aurora Cannabis’s Valuation Multiples
Canopy Growth and Aurora Cannabis are two prominent players in the cannabis sector. So far in 2020, Canopy Growth has outperformed cannabis ETFs.
Will Aphria’s Q3 Earnings Lift the Cannabis Sector?
Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.
Bruce Linton: WEED and CRON Can Handle COVID-19 Storm
On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.
What Can You Expect from Marijuana Stocks in April?
As of April 3, Aurora Cannabis stock has fallen 10%, while Canopy Growth has fallen 8.1%. Cronos Group and Hexo have fallen 2.6% and 19.3% in April.
Comparing OrganiGram and Aphria’s Valuation Multiples
So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.
3 Cannabis Stocks Investors Should Watch as Markets Rebound
As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.
Coronavirus: Marijuana Industry Asks for Federal Business Relief
Currently, the cannabis industry has pleaded with the federal government to help cannabis businesses during these distressing times.
Cannabis Stocks Outperformed Broader Equity Markets Last Week
Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.
Will Curaleaf Beat Analysts’ Expectations in Q4?
Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.
Marijuana Sales Soar amid Coronavirus Pandemic
Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.
Why Did Bank of America Upgrade Aphria and OrganiGram?
On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.
What to Expect from Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.
Coronavirus Revealed Cannabis Supply Chain’s Pitfalls
The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain.
Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating
On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.
Will the Fed’s Rate Cut Help Marijuana Stocks?
The marijuana sector saw a sharp decline last week amid the global sell-off. The S&P 500 fell by 8.8% in the week ending on March 13.
Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings
As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”
Alabama Gets Closer to Legalizing Medical Marijuana
On Thursday, WBRC reported that the Alabama Senate cleared Senate Bill 165. The bill will create the Compassion Act, which legalizes medical marijuana.
IIPR Looks Promising amid Struggling Cannabis Sector
As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.
Stifel Initiated Its Coverage on Aphria and HEXO
On Tuesday, MarketWatch reported that Stifel initiated its coverage on Aphria and HEXO. Stifel gave Aphria a “hold” and HEXO a “sell” rating.
Is the Coronavirus Impacting US Cannabis Sales?
The US cannabis industry has experienced lower sales amid the coronavirus chaos. The US stock market closed with a loss of 1.6% on March 6.
Mike Bloomberg Doesn’t Support Marijuana Legalization
Overall, Mike Bloomberg has the same view as President Trump and Joe Biden when it comes to marijuana legalization. He strongly opposes legalization.
OrganiGram: What Do Analysts Recommend Right Now?
As of February 28, OrganiGram Holdings (NASDAQ:OGI) was trading at 2.98 Canadian dollars—a fall of 6.6% since the beginning of this year.
Alabama’s Senate Committee Clears Medical Marijuana Bill
The Senate Judiciary Committee of Alabama cleared the bill that legalizes medical marijuana in the state. The committee voted 8-1 in favor of the proposed legislation.
Canopy Growth Surprised Investors with Its Q3 Earnings
Canopy Growth surprised investors and analysts with its third-quarter earnings. The stock rose and closed with a gain of 13.3% on the NYSE.
Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?
On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.
Marijuana Vape Products Expected in Alberta Stores
AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.
